USPTO serial 88340770
PRECISION AUTOLOGY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BENMAMAN, ALICE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PRECISION AUTOLOGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sherman Oaks, CA
Sherman Oaks, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Providing information in the nature of measurement evaluations and laboratory analysis in the fields of genetics, disease prediction and genetic disease treatment assessments; Data analysis in the fields of genetics, disease prediction and genetic disease treatment assessments for medical research purposes; Platform as a service (PAAS) featuring computer software platforms for predictive analytics in the field of genetics, disease prediction and treatment assessments; Software as a service (SAAS) services featuring software for machine learning in the fields of genetics, disease prediction and genetic disease treatment assessments; Providing temporary use of non-downloadable computer software for testing, data analysis, diagnosis, prognosis, reporting, and monitoring in the field of genetics, disease prediction and genetic disease treatment assessments; Platform as a service (PAAS) featuring computer software platforms for use in testing, data analysis, diagnosis, prognosis, reporting, and monitoring in the field of genetics, disease prediction and genetic disease treatment assessments; Web based non-downloadable software for machine learning, deep learning, and artificial intelligence in the field of genetics, disease prediction and genetic disease treatment assessments; Providing medical testing services in the field of genetic disease prediction and treatment for medical research purposes; medical laboratory services; medical laboratories; medical therapeutics research services, namely, computational genetics services in the nature of DNA testing and analysis for medical research purposes | ACTIVE | — |
| 044 | Medical stem cell therapy services; stem cell therapy services; medical services; providing medical information, consultancy and advisory services; medical services in the field of cell therapies and immunology; medical radiology services; providing medical information, namely, reporting of consumer authorized clinical testing results regarding genetics and disease prediction directly to the patient; providing medical information in the field of genetics disease diagnosis and prognosis; providing medical information in the field of predicting genetics disease and treating genetic diseases; providing medical information to medical professionals and patients in the form of reports in the fields of genetics and genetic diseases; Medical data analysis services for diagnostic and treatment purposes provided by medical laboratories in the fields of genetics and genetic disease prediction; Medical diagnostic reporting services in the fields of genetics and genetic disease prediction; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the fields of genetics and genetic diseases; Medical testing for diagnostic and treatment purposes in the field of genetic diseases; Medical analysis services, namely, conducting medical diagnostic testing to determine risk factors for diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 27, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 27, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 6, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 5, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Aug 5, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 18, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jul 18, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 20, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jan 18, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jan 18, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 14, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 14, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 14, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 14, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 14, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 22, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 20, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 20, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 20, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 21, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 26, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 26, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 6, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 21, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 17, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 17, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 17, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 15, 2019 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 15, 2019 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 15, 2019 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 16, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 9, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 30, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 30, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2019 | NWAP | NEW APPLICATION ENTERED | — |